Dr. Weintraub notes UBT251 targets the same GLP-1, GIP and glucagon receptors as retatrutide and showed large weight loss in a short phase 2 trial.
Recap by typeshit. Post by @mweintraubmd on Instagram.
In mice, GLP-1 receptor signaling mainly calmed inflammation while GLP-2 receptor signaling helped the intestine repair after T cell attack, researchers report.
Talker Research polled 2,000 Americans for aesthetics company Revance. Of 1,402 GLP-1 users, over 24% reported a new identity shift after starting the drugs.
Raw numbers pointed to higher AMD risk with GLP-1 drugs, but researchers say the pattern reversed once heart and metabolic factors were accounted for.
The Havre de Grace center opened a research building and will test whether the pairing cuts alcohol cravings. The study starts in early 2027, results about two years later.
JAMA flags unapproved GLP-1 drugs sold without regulation, pointing to unknown contents and safety concerns for buyers chasing cheaper shots.
A short social post on the body changes that can follow rapid weight loss on Ozempic and Wegovy, including the much discussed Ozempic face.
Loading…